Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study
Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study
Prostate Cancer and Prostatic Diseases advance online publication, September 24 2013.
doi:10.1038/pcan.2013.34
Authors: A Lustman, S Nakar, A D Cohen
& S Vinker
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: A LustmanS NakarA D CohenS Vinker Tags: hydrophobic statins hydrophilic statins prevalence Source Type: research
More News: Cancer | Cancer & Oncology | Cholesterol | Prostate Cancer | Statin Therapy | Study | Urology & Nephrology